Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Christy Osgood
U.S. Food and Drug Administration - Office of Oncologic Diseases
Silver Spring, MD
United States
Contact
U.S. Food and Drug Administration - Office of Oncologic Diseases
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
69
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Overall Survival in Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer Treated with a CDK 4/6 Inhibitor Plus Fulvestrant: A U.S. Food and Drug Administration Pooled Analysis
Number of pages: 20
Posted: 23 Jun 2021
Jennifer J. Gao
,
Joyce Cheng
,
Tatiana M. Prowell
,
Erik Bloomquist
,
Shenghui Tang
,
Suparna B. Wedam
,
Melanie Royce
,
Danielle Krol
, Christy Osgood,
Gwynn Ison
,
Rajeshwari Sridhara
,
Richard Pazdur
,
Julia A. Beaver
and
Laleh Amiri-Kordestani
Government of the United States of America - Division of Oncology Products, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Oncology Center of Excellence, U.S. Food and Drug Administration - Oncology Center of Excellence, U.S. Food and Drug Administration - Oncology Center of Excellence and Government of the United States of America - Office of Hematology and Oncology Products
Downloads
69
(883,195)
View PDF
Download
Abstract:
Feedback